-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recent data show that China has signed more than 200 "one/belt/one/road" cooperation documents
with 149 countries and 32 international organizations.
According to the data released by the General Administration of Customs, in the first half of 2022, the total amount of pharmaceutical trade between China and countries along the "One / Belt / One / Road" reached 35.
152 billion US dollars, a year-on-year increase of 1.
52%, and the bilateral trade volume hit a new high
in the same period of previous years.
Among them, the export value was 27.
235 billion US dollars and the import value was 7.
917 billion US dollars
.
In fact, in the past five years (2016-2021), China's import and export volume of pharmaceutical trade in the markets along the "one/belt/one/road" has increased year by year (see figure for details).
The export value of traditional Chinese medicine increased by 16.
75% year-on-year In the first half of this year, the amount of traditional Chinese medicine products exported by China to markets along the "one/belt/one/road" was US$905 million, a year-on-year increase of 16.
75%.
The highest proportion of export market share in the segment is plant extracts, with an export value of 478 million US dollars, a year-on-year increase of 35.
56%, the fastest
growth rate.
Different from the year-on-year increase in the export value of traditional Chinese medicine, from January to June this year, in the field of medical devices, China's total trade with the market along the "one/belt/one/road" reached 17.
481 billion US dollars, of which the export value was 14.
099 billion US dollars, a year-on-year decrease of 1.
33%.
From the perspective of sub-categories, the export market scale of dental equipment and materials has the fastest growth rate, with a year-on-year increase of 27.
44%; Disposable consumables accounted for the largest proportion, with an export value of 5.
968 billion US dollars, a year-on-year increase of 15.
80%.
In the first half of 2022, the export value of markets along the "one/belt/one/road" of western medicine products fell by 2.
05% year-on-year to US$12.
231 billion
.
Among them, the export of APIs is still strong, with an export value of 9.
328 billion US dollars, a year-on-year increase of 41.
19 percentage points; the export of Western patent medicines increased steadily by 9.
67%, with an export value of 1.
186 billion US dollars; biochemical drugs were affected by the decline in exports of new coronavirus vaccines, with an export value of 1.
718 billion US dollars, a year-on-year decline of 64.
21%.
。 Customs data show that South Korea, Vietnam and Italy are the top three markets for China's pharmaceutical trade exports along the "One Belt/One Road", with exports of US$2.
865 billion, US$1.
736 billion and US$1.
688 billion
respectively in the first half of this year.
South Korea From January to June this year, the bilateral pharmaceutical trade volume between China and South Korea reached a record high, reaching 3.
753 billion US dollars, a year-on-year increase of 5.
11%.
Among them, China's exports to South Korea were 2.
865 billion US dollars, a year-on-year increase of 10.
04%; The import value was 888 million US dollars, down 8.
18%
year-on-year.
From the perspective of the structure of pharmaceutical products, China's most exported product category to South Korea is medical devices, and the export value of this field to South Korea in the first half of 2022 was 1.
226 billion US dollars, a year-on-year decline of 4.
29%.
Western medicine products followed, with an export value of US$1.
475 billion, a year-on-year increase of 23.
96%; Traditional Chinese medicine products accounted for the smallest share of exports to South Korea, with an export value of US$164 million, a year-on-year increase of 23.
62%.
Vietnam In the first half of this year, the bilateral pharmaceutical trade volume between China and Vietnam reached 1.
982 billion US dollars, a year-on-year increase of 17.
80%.
Among them, China's exports to Vietnam were 1.
736 billion US dollars, a year-on-year increase of 20.
28%; The import value was 247 million US dollars, a year-on-year increase of 2.
88%.
In terms of trade scale, Vietnam is China's second largest pharmaceutical trading partner
along the "One Belt/One Road".
From the perspective of the structure of pharmaceutical products exported, the largest product category is medical devices, with an export value of 867 million US dollars in the first half of the year, a year-on-year increase of 5.
69%; Traditional Chinese medicine accounted for the smallest proportion, with an export value of US$172 million, down 33.
29% year-on-year; The export value of western medicines was 541 million US dollars, a year-on-year increase of 30.
25%.
Italy Italy is China's third largest pharmaceutical trade partner along the "One Belt/One Road", with bilateral pharmaceutical trade volume of US$3.
142 billion in the first half of this year, down 1.
02%
year-on-year.
Among them, China's exports to Italy were 1.
688 billion US dollars, a year-on-year increase of 4.
01%; The import value was 1.
454 billion US dollars, down 6.
28%
year-on-year.
From the perspective of the structure of pharmaceutical products exported to Italy, Western medicine accounted for the largest proportion, with the export value of such products in the first half of the year being 1 billion US dollars, a year-on-year increase of 48.
40%; The export value of medical devices was 644 million US dollars, down 29.
76% year-on-year; The export market of traditional Chinese medicines is small, only 44 million US dollars, a year-on-year increase of 10.
43%.
Overall, in the first half of this year, although due to the repeated and severe and complex international environment of the new crown pneumonia epidemic, the export of some pharmaceutical products in China has shown a trend of ups and downs, but the market demand for APIs and medical devices is still stable, and exports to markets along the "one/belt/one/road" continue to show a growing trend
.
At the same time, with the continuous development of China's pharmaceutical innovation, more cost-effective Chinese innovative drugs and biosimilars in the future will also have the opportunity to expand the market along the "one/belt/road", and the export structure of China's pharmaceutical products is expected to be further optimized
.
(Contributed by China Chamber of Commerce for Import and Export of Medicines and Health Products)
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). 
